Chemoinformaics analysis of 2-Hydroxyfuranodiene
| Molecular Weight | 232.323 | nRot | 0 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 14 |
| Exact Molecular Weight | 232.146 | nRing | 2 |
| Solubility: LogS | -4.344 | nHRing | 1 |
| Solubility: LogP | 2.821 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 5 |
| nHA | 2 | APOL | 39.9899 |
| nHD | 1 | BPOL | 21.8001 |
| QED | 0.696 |
| Synth | 4.366 |
| Natural Product Likeliness | 2.814 |
| NR-PPAR-gamma | 0.244 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.012 |
| Pgp-sub | 0.185 |
| HIA | 0.558 |
| CACO-2 | -4.636 |
| MDCK | 0.0000235 |
| BBB | 0.252 |
| PPB | 0.921633 |
| VDSS | 0.528 |
| FU | 0.0297365 |
| CYP1A2-inh | 0.229 |
| CYP1A2-sub | 0.433 |
| CYP2c19-inh | 0.438 |
| CYP2c19-sub | 0.255 |
| CYP2c9-inh | 0.198 |
| CYP2c9-sub | 0.68 |
| CYP2d6-inh | 0.064 |
| CYP2d6-sub | 0.863 |
| CYP3a4-inh | 0.102 |
| CYP3a4-sub | 0.3 |
| CL | 8.886 |
| T12 | 0.634 |
| hERG | 0.006 |
| Ames | 0.016 |
| ROA | 0.251 |
| SkinSen | 0.248 |
| Carcinogencity | 0.104 |
| EI | 0.015 |
| Respiratory | 0.678 |
| NR-Aromatase | 0.037 |
| Antiviral | Yes |
| Prediction | 0.843442 |